Kinfo
ImageneBio Inc. logo

ImageneBio Inc.

IMANASDAQHealthcare·US · USD
$3.97
-0.13 (-3.29%)
Prices as of November 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap45.07M USD
Enterprise value-87.64M USD
Trailing P/E-0.40
Forward P/E-0.95
PEG ratio0.02
Price / sales56.33
Price / book0.33
Profitability
Gross margin0.00%
Operating margin-6056.38%
Profit margin0.00%
Return on assets-43.06%
Return on equity-82.68%
Income (TTM)
Revenue800.00K USD
Gross profit0.00 USD
EBITDA-58.37M USD
Net income-53.33M USD
Diluted EPS-$4.09
Rev. growth (YoY)0.00%
Balance sheet
Total cash136.15M USD
Total debt1.91M USD
Debt / equity1.35
Current ratio21.47
Book value / share$12.60
Cash flow (TTM)
Operating cash flow-52.59M USD
Levered free cash flow-23.21M USD
Shares & price
Shares outstanding11.28M
Float5.83M
Held by institutions54.48%
Beta0.00
50-day MA$4.53
200-day MA$5.56
52-week high$8.84
52-week low$3.88
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-05-0.98-0.63+35.71%2026-05-07-0.66-0.95−43.94%2026-04-211.522.16+42.11%2026-03-100.260.30+15.38%
About ImageneBio Inc.

ImageneBio Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for immunological, autoimmune, and inflammatory diseases. Its lead program, IMG-007, is a non-depleting anti-OX40 monoclonal antibody designed to modulate OX40 receptor signaling on activated T cells, with development centered on conditions such as atopic dermatitis and alopecia areata. The company also explores broader applications in immune-mediated disorders, reflecting a research pipeline built around differentiated treatment approaches for chronic inflammatory disease. Based in San Diego, California, ImageneBio Inc. plays a specialized role in the biotechnology market by advancing targeted antibody-based therapies aimed at improving disease control in areas with significant unmet medical need.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Kristin Yarema Ph.D.
Employees
18
Headquarters
San Diego, CA, United States

Frequently asked questions about ImageneBio Inc.